ABO Blood Type and Hematoma Expansion After Intracerebral Hemorrhage: An Exploratory Analysis
Authors:
- David RohDRDavid Roh
- Andrew MartinAMAndrew Martin
- Chung-Huan SunCSChung-Huan Sun
- Andrew EisenbergerAEAndrew Eisenberger
- Amelia BoehmeABAmelia Boehme
- Mitchell S. V. ElkindMEMitchell S. V. Elkind
- Josephine U. PucciJPJosephine U. Pucci
- Santosh MurthySMSantosh Murthy
- Hooman KamelHKHooman Kamel
- Lauren SansingLSLauren Sansing
- Soojin ParkSPSoojin Park
- Sachin AgarwalSASachin Agarwal
- 13 December 2018
- journal article
- research article
- Published by Springer Nature in Neurocritical Care
- Vol. 31 (1) , 66-71
Abstract
Background/Purpose Blood type has become an increasingly recognized risk factor for coagulopathy. We explored the association between blood type and hematoma expansion (HE) after intracerebral hemorrhage (ICH). Methods Spontaneous ICH patients prospectively enrolled in an ongoing ICH cohort study at Columbia University Irving Medical Center from 2009 to 2016 were evaluated. Primary ICH patients with admission blood type testing were evaluated for HE differences, defined as > 33% relative HE. The association of blood type with radiographic HE outcomes was assessed using multivariable logistic regression models. The association of blood type and poor clinical outcomes using modified Rankin Scale (mRS 4–6) was additionally explored. Results Of 272 ICH patients with blood type data and neuroimaging available to determine HE, there were 146 (54%) type-O, 82 (30%) type-A, 34 (13%) type-B, and 10 (3%) type-AB patients. No significant baseline demographic, clinical, or radiographic differences were noted between blood types. Type-B blood was associated with more HE compared to other blood types (OR 2.82; 95% CI 1.23–6.45) after adjusting for known covariates of HE (anticoagulant use, time to admission computed tomography scan, and baseline hematoma volume). No associations with blood type and poor 3 month mRS were identified, but these analyses were limited secondary to our smaller cohort. Conclusions There may be differences in HE after ICH in patients with different blood types. Further work is required to replicate these findings and identify the pathophysiologic mechanisms behind coagulopathy between blood types after ICH.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001873)
This publication has 14 references indexed in Scilit:
- ABO Blood Group and Risk of Thromboembolic and Arterial DiseaseCirculation, 2016
- ABO Blood Group as a Model for Platelet Glycan Modification in Arterial ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- Guidelines for the Management of Spontaneous Intracerebral HemorrhageStroke, 2015
- Predicting Hematoma Expansion After Primary Intracerebral HemorrhageJAMA Neurology, 2014
- ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke StudyJournal of Thrombosis and Haemostasis, 2014
- von Willebrand Factor Genetic Variant Associated With Hematoma Expansion After Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2013
- Volume-dependent effect of perihaematomal oedema on outcome for spontaneous intracerebral haemorrhagesJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Role of ABO blood group as a prognostic factor in patients with spontaneous intracerebral hemorrhageJournal of Thrombosis and Haemostasis, 2012
- ABO and Rh(D) phenotype frequencies of different racial/ ethnic groups in the United StatesTransfusion, 2004
- The ICH ScoreStroke, 2001